Shares in Otonomy, Inc. (OTIC) spiked 15% in pre-market trading after the biotech company disclosed statistical data on its vertigo drug Otividex and …
Otonomy Inc (NASDAQ:OTIC) magnetized Street-wide attention after Wednesday’s triumphant Phase III home run in Meniere’s, leading investors to send the stock racing up 83% …
OTIC stock fired to the roof after successful late-trial results in Meniere’s; Edward Nash cheers.
It’s a very rewarding trading day for investors in Otonomy Inc (NASDAQ:OTIC) with shares up over 80%, making the stock Wall Street’s bull …
